Education
About Us
Working with TipRanks
Follow Us
Phathom Pharmaceuticals (PHAT)
NASDAQ:PHAT
Phathom Pharmaceuticals (PHAT) Ownership Overview
11.16% Insiders
16.46% Mutual Funds
59.68% Other Institutional Investors
7.62% ETFs
5.09% Public Companies and Individual Investors
The ownership structure of Phathom Pharmaceuticals (PHAT) stock is a mix of institutional, retail, and individual investors. Approximately 83.75% of the company’s stock is owned by Institutional Investors, 11.16% is owned by Insiders, and 5.09% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
May 23, 2025 | xxxxxxxxxxxxx | $14591 | |
May 15, 2025 | xxxxxxxxxxxxx | $24455 | |
May 13, 2025 | xxxxxxxxxxxxx | $152686 | |
May 08, 2025 | xxxxxxxxxxxxx | $24950 |
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|---|---|---|
Mar 31, 2025 | xxxxxxxxxxxxx | $260618 | |
Mar 31, 2025 | xxxxxxxxxxxxx | $4713108 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 5,933,327 | Insider | 8.50% | 63,130,599 | |
| 2,659,580 | Institution | 3.81% | 28,297,931 | |
| 2,310,136 | Institution | 3.31% | 24,579,847 | |
| 1,781,345 | Institution | 2.55% | 18,953,511 | |
| 1,728,534 | Institution | 2.48% | 18,391,602 | |
| 1,579,095 | Institution | 2.26% | 16,801,571 | |
| 1,469,354 | Institution | 2.10% | 15,633,927 | |
| 1,101,868 | Insider | 1.58% | 11,723,876 | |
| 751,692 | Institution | 1.08% | 7,998,003 | |
| 746,710 | Institution | 1.07% | 7,944,994 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 2,310,136 | Institution | 3.31% | 24,579,847 | |
| 1,781,345 | Institution | 2.55% | 18,953,511 | |
| 1,579,095 | Institution | 2.26% | 16,801,571 | |
| 1,469,354 | Institution | 2.10% | 15,633,927 | |
| 746,710 | Institution | 1.07% | 7,944,994 | |
| 508,584 | Institution | 0.73% | 5,411,334 | |
| 467,837 | Institution | 0.67% | 4,977,786 | |
| 464,839 | Institution | 0.67% | 4,945,887 | |
| 429,607 | Institution | 0.62% | 4,571,018 | |
| 253,000 | Institution | 0.36% | 2,691,920 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 1,588,583 | Institution | 2.28% | 6,815,021 | |
| 984,883 | Institution | 1.41% | 10,479,155 | |
| 721,863 | Institution | 1.03% | 3,096,792 | |
| 521,935 | Institution | 0.75% | 5,553,388 | |
| 266,945 | Institution | 0.38% | 2,840,295 | |
| 228,143 | Institution | 0.33% | 2,427,442 | |
| 207,837 | Institution | 0.30% | 2,084,605 | |
| 199,814 | Institution | 0.29% | 857,202 | |
| 117,820 | Institution | 0.17% | 505,448 | |
| 88,330 | Institution | 0.13% | 939,831 |
FAQ
Who Owns Phathom Pharmaceuticals (PHAT)?
According to the latest TipRanks data, approximately 59.68% of the company's stock is held by institutional investors, 11.16% is held by insiders, and 5.09% is held by retail investors.
What percentage of Phathom Pharmaceuticals (PHAT) stock is held by institutional investors?
According to the latest TipRanks data, approximately 59.68% of Phathom Pharmaceuticals (PHAT) stock is held by institutional investors.
What percentage of Phathom Pharmaceuticals (PHAT) stock is held by retail investors?
According to the latest TipRanks data, approximately 5.09% of Phathom Pharmaceuticals (PHAT) stock is held by retail investors.
Who owns the most shares of Phathom Pharmaceuticals (PHAT)?
James Topper owns the most shares of Phathom Pharmaceuticals (PHAT).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.